InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
38%
T+90 mean return
+11.1%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by SAUNDERS BRENT L, Président Exécutif. Director active across 5 companies, notably Beauty Health Co. Aggregated, 25 reports have been recorded. Split: 5 buys · 0 sell. Total volume traded: €1.3m. Activity tracked since 4 May 2021. The latest transaction was disclosed on 22 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations25 total
2,886 shares@ US$15.920.0007% mcap2.2% of flowCommon Shares, No Par ValueSEC:0001860742-26-000071:0
120,000 shares@ US$1.01100.0% of flowCommon StockSEC:0001415889-25-014185:0
168,168 shares0Common Shares, No Par ValueSEC:0001127602-25-007260:0
73,782 shares@ US$17.8371.6% of flowCommon Shares, No Par ValueSEC:0001127602-24-030056:0
40,450 shares@ US$1.086.9% of flowClass A Common StockSEC:0001628280-24-036967:0
Ideal exit: 9 May 2025 (T+270)
32,250 shares@ US$15.66126.2% of flowCommon Shares, No Par ValueSEC:0001127602-24-021823:0
Ideal exit: 2 May 2025 (T+270)
3,711 shares@ US$16.889.8% of flowClass A Common StockSEC:0001628280-24-031586:0
187,919 shares0Common Shares, No Par ValueSEC:0001127602-24-007883:0
59,380 shares@ US$6.102657.6% of flowClass A Common StockSEC:0001628280-23-029854:0
Ideal exit: 12 May 2024 (T+270)
16,357 sharesClass A Common StockSEC:0001628280-23-022509:0
5,001 shares0Common StockSEC:0001209191-22-060763:0
35,581 sharesClass A Common StockSEC:0001818093-22-000031:0
35,581 sharesClass A Common StockSEC:0001818093-22-000031
6,812 shares@ US$12.240.089% mcap50.0% of flowClass A Common StockSEC:0001818093-22-000021:0
6,812 shares@ US$12.240.089% mcap100.0% of flowClass A Common StockSEC:0001818093-22-000021
17,600 shares@ US$14.48180.0015% mcap50.0% of flowCommon StockSEC:0000899243-22-000193:0
Ideal exit: 25 Sept 2022 (T+270)
17,600 shares@ US$14.48180.0015% mcap100.0% of flowCommon StockSEC:0000899243-22-000193
Ideal exit: 25 Sept 2022 (T+270)
4,180 shares0Common StockSEC:0001209191-21-069855
4,180 shares0Common StockSEC:0001209191-21-069855:0
30,963 shares0Class A Common StockSEC:0001818093-21-000067:0
30,963 shares0Class A Common StockSEC:0001818093-21-000067
11,500,000 shares0Class A Common StockSEC:0001818093-21-000010:0
11,500,000 shares0Class A Common StockSEC:0001818093-21-000010
11,500,000 shares0Class A Common StockSEC:0000899243-21-018999
11,500,000 shares0Class A Common StockSEC:0000899243-21-018999:0
25 of 25 declarations
About SAUNDERS BRENT L
Brent L. Saunders is Executive Chairman and Board Member at Beauty Health Co, Cisco Systems, Inc., and BridgeBio Pharma, Inc. In these roles, he participates in the strategic direction of the companies and in important decision-making. His experience in the health and technology sectors allows him to make significant contributions to discussions on growth and innovation.
